Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/34516
Immunomodulatory effect of mesenchymal stem cells on B cells
Journal Title
Director/Tutor
Additional contribution
Journal ISSN
Volume Title
Abstract
The research on T cell immunosuppression therapies has attracted most of the attention in clinical transplantation. However, B cells and humoral immune responses are increasingly acknowledged as crucial mediators of chronic allograft rejection. Indeed, humoral immune responses can lead to renal allograft rejection even in patients whose cell-mediated immune responses are well controlled. On the other hand, newly studied B cell subsets with regulatory effects have been linked to tolerance achievement in transplantation. Better understanding of the regulatory and effector B cell responses may therefore lead to new therapeutic approaches. Mesenchymal stem cells (MSC) are arising as a potent therapeutic tool in transplantation due to their regenerative and immunomodulatory properties.The research on MSCs has mainly focused on their effects onT cells and although data regarding the modulatory effects of MSCs on alloantigen-specific humoral response in humans is scarce, it has been demonstrated that MSCs significantly affect B cell functioning. In the present review we will analyze and discuss the results in this field.
Related resource
Subject (English)
Citation
Citation
FRANQUESA, Marcella, et al. Immunomodulatory effect of mesenchymal stem cells on B cells. Frontiers in Immunology. 2012. Vol. 3, num. 212. [consulted: 7 of October of 2026]. Available at: https://hdl.handle.net/2445/34516